Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)
Clinical trial NCT00100737 · TERMINATED
Trial details
- NCT number
- NCT00100737
- Sponsor
- Chiron Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.